Shared on27 Aug 25Fair value Increased 1.30%
With both the Future P/E and Net Profit Margin for Macquarie Group largely unchanged, the consensus analyst price target has seen only a marginal increase to A$221.24. What's in the News Macquarie Group is set to acquire a 40% minority stake in Portuguese hospital operator Luz Saúde, outbidding CVC Capital Partners and KKR, with the deal valuing Luz Saúde at over €1 billion.
Shared on23 Apr 25Fair value Decreased 4.08%
AnalystConsensusTarget has decreased revenue growth from 5.9% to 5.3%.
Shared on17 Apr 25Fair value Decreased 2.58%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Decreased 0.37%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25Fair value Decreased 1.08%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25Fair value Increased 1.84%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on12 Mar 25Fair value Increased 1.12%
AnalystConsensusTarget has increased revenue growth from 5.1% to 6.0% and decreased shares outstanding growth rate from 0.0% to -0.0%.